<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">RNA</journal-id>
<journal-id journal-id-type="iso-abbrev">RNA</journal-id>
<journal-id journal-id-type="publisher-id">RNA</journal-id>
<journal-title-group>
<journal-title>RNA</journal-title>
</journal-title-group>
<issn pub-type="ppub">1355-8382</issn>
<issn pub-type="epub">1469-9001</issn>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30042172</article-id>
<article-id pub-id-type="pmc">6140460</article-id>
<article-id pub-id-type="medline">9509184</article-id>
<article-id pub-id-type="publisher-id">RA</article-id>
<article-id pub-id-type="doi">10.1261/rna.066712.118</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT</article-title>
<alt-title alt-title-type="left-running">Harvey et al.</alt-title>
<alt-title alt-title-type="right-running">Coregulation of splicing by hnRNPM and ESRP1</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Harvey</surname>
<given-names>Samuel E.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Yilin</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Xiaodan</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gao</surname>
<given-names>Xin D.</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qiu</surname>
<given-names>Yushan</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ahn</surname>
<given-names>Jaegyoon</given-names>
</name>
<xref ref-type="aff" rid="af3">3</xref>
<xref ref-type="author-notes" rid="fn1">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiao</surname>
<given-names>Xinshu</given-names>
</name>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cheng</surname>
<given-names>Chonghui</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
</contrib-group>
<aff id="af1"><label>1</label>Lester and Sue Smith Breast Center, Department of Molecular and Human Genetics, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA</aff>
<aff id="af2"><label>2</label>Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA</aff>
<aff id="af3"><label>3</label>Department of Integrative Biology and Physiology and the Molecular Biology Institute, University of California Los Angeles, Los Angeles, California 90095, USA</aff>
<author-notes>
<fn fn-type="present-address" id="fn1">
<label>4</label>
<p><bold>Present address:</bold> Department of Computer Science and Engineering, Incheon National University, Incheon 22012, South Korea</p>
</fn>
<corresp>Corresponding author: <email>chonghui.cheng@bcm.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>10</month>
<year>2018</year>
</pub-date>
<volume>24</volume>
<issue>10</issue>
<fpage>1326</fpage>
<lpage>1338</lpage>
<history>
<date date-type="received">
<day>10</day>
<month>4</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>7</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>
<ext-link ext-link-type="uri" xlink:href="http://www.rnajournal.org/site/misc/terms.xhtml">© 2018 Harvey et al.; Published by Cold Spring Harbor Laboratory Press for the RNA Society</ext-link>
</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
<license-p>This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see <ext-link ext-link-type="uri" xlink:href="http://rnajournal.cshlp.org/site/misc/terms.xhtml">http://rnajournal.cshlp.org/site/misc/terms.xhtml</ext-link>). After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="1326.pdf"></self-uri>
<abstract>
<p>The epithelial–mesenchymal transition (EMT) is a fundamental developmental process that is abnormally activated in cancer metastasis. Dynamic changes in alternative splicing occur during EMT. ESRP1 and hnRNPM are splicing regulators that promote an epithelial splicing program and a mesenchymal splicing program, respectively. The functional relationships between these splicing factors in the genome scale remain elusive. Comparing alternative splicing targets of hnRNPM and ESRP1 revealed that they coregulate a set of cassette exon events, with the majority showing discordant splicing regulation. Discordant splicing events regulated by hnRNPM show a positive correlation with splicing during EMT; however, concordant events do not, indicating the role of hnRNPM in regulating alternative splicing during EMT is more complex than previously understood. Motif enrichment analysis near hnRNPM–ESRP1 coregulated exons identifies guanine–uridine rich motifs downstream from hnRNPM-repressed and ESRP1-enhanced exons, supporting a general model of competitive binding to these <italic>cis</italic>-elements to antagonize alternative splicing. The set of coregulated exons are enriched in genes associated with cell migration and cytoskeletal reorganization, which are pathways associated with EMT. Splicing levels of coregulated exons are associated with breast cancer patient survival and correlate with gene sets involved in EMT and breast cancer subtyping. This study identifies complex modes of interaction between hnRNPM and ESRP1 in regulation of splicing in disease-relevant contexts.</p>
</abstract>
<kwd-group>
<kwd>RNA binding proteins</kwd>
<kwd>hnRNPM</kwd>
<kwd>ESRP1</kwd>
<kwd>alternative splicing</kwd>
<kwd>EMT</kwd>
</kwd-group>
<funding-group>
<award-group id="funding-1">
<funding-source>
<institution-wrap>
<institution>US National Institutes of Health Ruth L. Kirschstein National Research Service Award </institution>
<institution-id institution-id-type="open-funder-registry">10.13039/100000002</institution-id>
</institution-wrap>
</funding-source>
<award-id>1F30CA196118</award-id>
</award-group>
<award-group id="funding-2">
<funding-source>
<institution-wrap>
<institution>US National Institutes of Health </institution>
<institution-id institution-id-type="open-funder-registry">10.13039/100000002</institution-id>
</institution-wrap>
</funding-source>
<award-id>CA182467</award-id>
<award-id>GM110146</award-id>
<award-id>HG006264</award-id>
<award-id>HG009417</award-id>
</award-group>
<award-group id="funding-3">
<funding-source>Cancer Prevention Research Institute of Texas Scholar in Cancer Research</funding-source>
</award-group>
</funding-group>
<counts>
<page-count count="13"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>